祥生医疗
(688358)
| 流通市值：28.93亿 | | | 总市值：28.93亿 |
| 流通股本：1.12亿 | | | 总股本：1.12亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 951,228,143.05 | 942,834,475.81 | 746,693,770.3 | 688,772,839.29 |
| 应收票据及应收账款 | 180,033,703.05 | 176,028,703.49 | 175,938,685.04 | 154,546,529.16 |
| 应收账款 | 180,033,703.05 | 176,028,703.49 | 175,938,685.04 | 154,546,529.16 |
| 预付款项 | 5,126,773.84 | 7,352,623.96 | 7,747,944.09 | 5,157,934.18 |
| 其他应收款合计 | 2,491,645.31 | 4,158,885.8 | 1,658,505.99 | 3,471,024.87 |
| 存货 | 135,933,909.68 | 119,771,387.66 | 109,744,272.5 | 135,928,319.19 |
| 其他流动资产 | 14,763,543.84 | 10,814,952.44 | 6,063,821.66 | 12,899,685.35 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,409,841,502.17 | 1,416,233,030.98 | 1,360,337,525.55 | 1,341,325,853.87 |
| 非流动资产: | | | | |
| 固定资产 | 76,852,533.07 | 75,431,680.06 | 77,099,197.36 | 79,622,739.32 |
| 在建工程 | 56,607,614.14 | 56,899,296.62 | 55,810,480.52 | 55,564,678.93 |
| 使用权资产 | 5,749,876.45 | 6,516,355.64 | 7,282,834.83 | 8,049,314.02 |
| 无形资产 | 20,653,143.46 | 20,876,083.86 | 21,105,571.26 | 21,074,176.88 |
| 长期待摊费用 | 926,666.2 | 1,180,612.91 | 653,944.91 | 690,275.21 |
| 递延所得税资产 | 8,554,338.45 | 9,382,963.93 | 8,604,307.85 | 9,266,077.39 |
| 其他非流动资产 | 7,500,066.16 | 9,002,431.83 | 6,947,146.46 | 6,894,987.16 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 176,844,237.93 | 179,289,424.85 | 177,503,483.19 | 181,162,248.91 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,586,685,740.1 | 1,595,522,455.83 | 1,537,841,008.74 | 1,522,488,102.78 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 94,390,666.32 | 77,219,229.41 | 61,819,024.12 | 84,571,607.29 |
| 其中：应付票据 | 1,713,701.83 | 623,848.17 | - | - |
| 应付账款 | 92,676,964.49 | 76,595,381.24 | 61,819,024.12 | 84,571,607.29 |
| 合同负债 | 17,055,428.9 | 22,714,399.31 | 19,654,103.34 | 15,997,985.72 |
| 应付职工薪酬 | 16,052,116.8 | 13,314,420.74 | 10,192,527.39 | 19,104,930.85 |
| 应交税费 | 5,192,105.09 | 9,781,288.5 | 6,370,127.68 | 7,125,191.16 |
| 其他应付款合计 | 63,594,781.57 | 95,395,203.98 | 6,042,385.32 | 7,547,320.99 |
| 应付股利 | 57,456,000 | 89,499,802.4 | - | - |
| 一年内到期的非流动负债 | 4,052,349.05 | 4,000,554.07 | 4,051,009.94 | 4,022,657.85 |
| 其他流动负债 | 14,838.53 | 20,283.33 | 16,759.53 | 22,589.77 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 200,352,286.26 | 222,445,379.34 | 108,145,937.32 | 138,392,283.63 |
| 非流动负债: | | | | |
| 租赁负债 | 3,361,495.67 | 4,327,318.86 | 5,553,937.87 | 6,316,049.67 |
| 预计负债 | 5,260,158.51 | 4,779,773.49 | 6,675,266.44 | 6,412,005.7 |
| 递延收益 | 1,973,337.44 | 2,042,815.96 | 2,289,687 | 2,299,150.68 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 10,594,991.62 | 11,149,908.31 | 14,518,891.31 | 15,027,206.05 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 210,947,277.88 | 233,595,287.65 | 122,664,828.63 | 153,419,489.68 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 112,124,537 | 112,124,537 | 112,124,537 | 112,124,537 |
| 资本公积 | 906,308,445.25 | 906,231,787.39 | 905,782,930.08 | 905,220,432.77 |
| 减:库存股 | 10,094,650.08 | 10,094,650.08 | 10,094,650.08 | 10,094,650.08 |
| 其他综合收益 | -3,548,659.06 | -218,387.44 | -216,148.45 | -221,745.4 |
| 盈余公积 | 56,062,268.5 | 56,062,268.5 | 56,062,268.5 | 56,062,268.5 |
| 未分配利润 | 314,886,520.61 | 297,821,612.81 | 351,517,243.06 | 305,977,770.31 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,375,738,462.22 | 1,361,927,168.18 | 1,415,176,180.11 | 1,369,068,613.1 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,375,738,462.22 | 1,361,927,168.18 | 1,415,176,180.11 | 1,369,068,613.1 |
| 负债和股东权益合计 | 1,586,685,740.1 | 1,595,522,455.83 | 1,537,841,008.74 | 1,522,488,102.78 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-19 | 2024-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |